Member since 22 December 201701 February 2018 at 14:29
The so-called racial gap in breast cancer care has long been suggested by researchers, with black and Hispanic women less likely to get recommended breast cancer treatments than white patients. Researchers claim financial factors such as economic and social class or access to insurance alone can't explain this "gap”. Even after accounting for those differences, racial disparities in breast cancer care can still be found. For hormone receptor testing there may not be such differences but the gap persists in other interventions. For instance, black women have lower odds of receiving recommended treatments: interventions like mastectomy or breast-conserving therapy or even chemotherapy. The sad part is, these disparities persist even after many studies accounted for insurance coverage and socioeconomic status. People often are quick to blame the so-called "racial gap" on income or insurance, but the fact that the gap exists independently of these factors clearly hints there are more "hidden" racial biases in our healthcare system.
Vulvar Paget's disease is a type of skin cancer of the Vulva. It presents as redness, velvety appearance with white islands of tissue. This is accompanied by itching and pain. If you have any such symptoms, contact your oncologist/gynaecologist for further treatment.
Early signs of cancer could be unexplained weight loss, a lump or swelling, unusual bleeding, persistent fatigue or changes in skin. Some people also notice long-lasting coughs or changes in bowel habits. If you experience any of these symptoms, it is recommended to consult the best oncologist avail....
Nidii Berwal
The so-called racial gap in breast cancer care has long been suggested by researchers, with black and Hispanic women less likely to get recommended breast cancer treatments than white patients. Researchers claim financial factors such as economic and social class or access to insurance alone can't explain this "gap”. Even after accounting for those differences, racial disparities in breast cancer care can still be found. For hormone receptor testing there may not be such differences but the gap persists in other interventions. For instance, black women have lower odds of receiving recommended treatments: interventions like mastectomy or breast-conserving therapy or even chemotherapy. The sad part is, these disparities persist even after many studies accounted for insurance coverage and socioeconomic status. People often are quick to blame the so-called "racial gap" on income or insurance, but the fact that the gap exists independently of these factors clearly hints there are more "hidden" racial biases in our healthcare system.